Synergy CHC Corp. (SNYR)
1.835
+0.02
(+1.38%)
USD |
NASDAQ |
Dec 31, 16:00
1.835
0.00 (0.00%)
After-Hours: 18:50
Synergy CHC EPS Diluted (Quarterly): 0.0124 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | -1.226 |
| NRX Pharmaceuticals, Inc. | -0.2649 |
| NeOnc Technologies Holdings, Inc. | -0.4485 |
| BioVie, Inc. | -0.984 |
| DocGo, Inc. | -0.2839 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.1253M |
| Revenue (Quarterly) | 8.010M |
| Total Expenses (Quarterly) | 7.885M |
| Enterprise Value | 44.37M |
| Gross Profit Margin (Quarterly) | 70.50% |
| Profit Margin (Quarterly) | 1.56% |
| Earnings Yield | 15.91% |
| Operating Earnings Yield | 37.44% |
| Normalized Earnings Yield | 6.708 |